Oral Proteins & Peptides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

The Global Oral Proteins & Peptides Market was valued at USD 1.33 billion in 2024 and is expected to experience significant growth during the forecast period, with a compound annual growth rate (CAGR) of 9.42% through 2030. This market is rapidly expanding within the pharmaceutical and biotechnology sectors. Oral proteins and peptides are bioactive molecules that can be taken orally, typically in the form of tablets, capsules, or liquids, providing an alternative to injectable therapies. This method of administration offers multiple advantages, including improved patient compliance, reduced discomfort, and lower healthcare costs.

Key Market Drivers:

Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a key factor driving the growth of the oral proteins and peptides market. As the global population ages and lifestyles become more sedentary and unhealthy, the incidence of chronic diseases is increasing. This leads to a larger patient pool that could benefit from oral protein and peptide treatments. According to the World Health Organization, noncommunicable diseases (NCDs) were responsible for 43 million deaths, accounting for 75% of all global deaths unrelated to pandemics. Cardiovascular diseases were the leading cause with 19 million deaths, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million). Notably, low- and middle-income countries accounted for 73% of these NCD-related deaths.

Patients with chronic conditions are increasingly seeking convenient treatment options. Many require long-term or lifelong therapies, and traditional methods such as injections or infusions can be burdensome. Oral proteins and peptides provide a more patient-friendly alternative, as they can be taken in the form of a pill or liquid, eliminating the need for painful, frequent injections. Additionally, non-adherence to prescribed treatments is a significant challenge in managing chronic diseases. Oral formulations help address this issue by increasing patient compliance, as treatments that are easier to administer and less intrusive encourage better adherence and lead to improved health outcomes.

Key Market Challenges:

Stability and Bioavailability

A major challenge in the oral administration of proteins and peptides is their susceptibility to degradation in the harsh environment of the gastrointestinal tract. Ensuring their stability and maintaining adequate bioavailability remains a complex issue that requires advanced formulation technologies.

Key Market Trends:

Advancements in Nanotechnology and Drug Delivery Systems

Nanotechnology is transforming drug delivery in the oral proteins and peptides market. Nanoparticles and nanocarriers are being developed to encapsulate and protect these sensitive molecules, enabling more precise delivery and enhanced bioavailability. These innovations are expected to expand the range of treatable diseases and improve therapeutic outcomes.

Key Market Players:

• AbbVie Inc.
• Merck & Co., Inc.
• Pfizer Inc.
• Novo Nordisk A/S
• Hoffmann-La Roche Inc.
• Sanofi S.A.
• AstraZeneca PLC
• Bristol-Myers Squibb Co.
• Tarsa Therapeutics Inc.
• Novartis AG

Report Scope:

This report segments the Global Oral Proteins & Peptides Market into the following categories, with detailed insights into each:

By Drug Type:

• Calcitonin
• Insulin
• Linaclotide
• Octreotide
• Plecanatide

By Application:

• Bone Diseases
• Diabetes
• Gastric & Digestive Disorders
• Hormonal Disorders

By Region:

North America:

United States, Canada, Mexico

Europe:

Germany, United Kingdom, France, Italy, Spain

Asia-Pacific:

China, Japan, India, Australia, South Korea

South America:

Brazil, Argentina, Colombia

Middle East & Africa:

South Africa, Saudi Arabia, UAE, Kuwait

Competitive Landscape and Company Profiles:

This section offers an in-depth analysis of the major players in the Global Oral Proteins & Peptides Market.

Available Customizations:

TechSci Research provides customized reports tailored to specific market needs. The following customization options are available:

• Detailed analysis and profiling of up to five additional market players.

This product will be delivered within 1-3 business days.